

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Sodium Channel ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolperisone HCl | ✔ | 99% | |||||||||||||||||
| Triamterene |
+++
ENaC, IC50: 4.5 μM |
98% | |||||||||||||||||
| Lamotrigine | ✔ | 98% | |||||||||||||||||
| Vinpocetine | ✔ | 98% | |||||||||||||||||
| Zonisamide | ✔ | 99% | |||||||||||||||||
| Dronedarone HCl | ✔ | 95% | |||||||||||||||||
| Procainamide HCl | ✔ | 99% | |||||||||||||||||
| Bupivacaine HCl | ✔ | 99+% | |||||||||||||||||
| Benzocaine | ✔ | 98% | |||||||||||||||||
| Carbamazepine |
++
Sodium channel, IC50: 131 μM |
98% | |||||||||||||||||
| Quinidine sulfate dihydrate | ✔ | 98% | |||||||||||||||||
| Ibutilide fumarate | ✔ | 99%+ | |||||||||||||||||
| Dibucaine HCl | ✔ | 99+% | |||||||||||||||||
| Mexiletine HCl | ✔ | 99% | |||||||||||||||||
| Phenytoin | ✔ | 99+% | |||||||||||||||||
| Camostat Mesylate |
+++
epithelial sodium channel (ENaC), IC50: 50 nM |
99%+ | |||||||||||||||||
| Levobupivacaine | ✔ | 97+% | |||||||||||||||||
| Oxcarbazepine |
+
sodium channel, IC50: 160 μM |
98% | |||||||||||||||||
| Amiloride HCl dihydrate | ✔ | 97% | |||||||||||||||||
| Ambroxol | 98+% | ||||||||||||||||||
| Primidone | ✔ | 99% | |||||||||||||||||
| Propafenone | ✔ | 99% | |||||||||||||||||
| A-803467 |
++++
Na(V1.8) channel, IC50: 8 nM |
99%+ | |||||||||||||||||
| Rufinamide | ✔ | 99% | |||||||||||||||||
| Phenytoin sodium | ✔ | 98% | |||||||||||||||||
| Proparacaine HCl |
+
Voltage-gated sodium channel, ED50: 3.4 mM |
98+% | |||||||||||||||||
| Amiloride HCl | ✔ | 98% | |||||||||||||||||
| Riluzole | ✔ | 97% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | A-803467 is a potent and selective tetrodotoxin-resistant Nav1.8 sodium channel blocker (IC50=8 nM). A-803467 (20 mg/kg, i.v.) blocked mechanically evoked firing of wide dynamic range neurons in the rat spinal dorsal horn. A-803467 also dose-dependently reduced mechanical allodynia in a variety of rat pain models including: spinal nerve ligation (ED(50) = 47 mg/kg, i.p.), sciatic nerve injury (ED(50) = 85 mg/kg, i.p.), capsaicin-induced secondary mechanical allodynia (ED(50) approximately 100 mg/kg, i.p.), and thermal hyperalgesia after intraplantar complete Freund's adjuvant injection (ED(50) = 41 mg/kg, i.p.)[3]. A-803467 selectively and significantly reverses the ABCG2-mediated multidrug resistance. A-803467 (7.5 μM) significantly increased the intracellular accumulation of [(3)H]-mitoxantrone by inhibiting the transport activity of ABCG2, without altering its expression levels. In addition, A-803467 stimulated the ATPase activity in membranes overexpressed with ABCG2. In a murine model system, combination treatment of A-803467 (35 mg/kg) and topotecan (3 mg/kg) significantly inhibited the tumor growth in mice xenografted with ABCG2-overexpressing cancer cells[4]. A-803467 significantly shortened ventricular effective refractory period, APD90, and ventricular fibrillation threshold compared to control. In the A-803467 group, the incidence of ventricular arrhythmias was significantly higher compared to control. A-803467 suppressed the slowing of heart rate response to high-frequency electrical stimulation of the anterior right GP(ganglionated plexi), suggesting that A-803467 could inhibit GP activity[5]. |
| Concentration | Treated Time | Description | References | |
| HEK cells | 8 nM | A-803467 inhibited inward currents in HEK cells | Arthritis Res Ther. 2012 Jan 7;14(1):R5. | |
| ND7/23 cells | 30 nM | Evaluate the selective inhibition of Nav1.8 current by A-803467 | Circ Res. 2012 Jul 20;111(3):322-32. | |
| HEK-293 cells | 8 nM | Block human Nav1.8 channels | Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5. | |
| GH3 cells | 3 µM | Suppressed the peak density of voltage-gated Na+ current (INa) | Int J Mol Sci. 2020 Mar 31;21(7):2416. | |
| Human hypertrophic cardiomyocytes | 30 nM | 10 min | Significantly reduced the persistent Na+ current (INaL), shortened action potential duration, and decreased sarcoplasmic reticulum Ca2+ leak | ESC Heart Fail. 2019 Feb;6(1):154-163. |
| Human atrial cardiomyocytes | 30 nM | 15 minutes | To investigate the effect of NaV1.8 inhibition on late sodium current, results showed A-803467 significantly reduced late sodium current. | Basic Res Cardiol. 2020 Feb 20;115(2):20. |
| Small-sized DRG neurons | 5 µM | Used to block Nav1.8 currents and confirm the modulation effect of BmK I on Nav1.8 | Protein Cell. 2015 Jun;6(6):443-52. | |
| Rat dorsal root ganglion neurons | 140 nM | Block TTX-R currents and inhibit action potential generation | Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5. | |
| ND-7/23 cells | 0.73±0.08 µM (IC50) | Determination of the half-maximal inhibitory concentration (IC50) of A-803467 on Na v1.8 | Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2208211119. | |
| TSA201 cells | 100 nM | To investigate the electrophysiological effects of A-803467 on SCN10A-SCN5A-SCN3B co-transfected TSA201 cells. Results showed that A-803467 significantly reduced INa,P and INa,L and altered channel kinetics. | J Am Heart Assoc. 2016 Nov 2;5(11):e004050. | |
| Mouse dorsal root ganglion neurons | 500 nM | A-803467 blocked repetitive action potential firing in DRG neurons of both HDC−/− and wild-type mice. | CNS Neurosci Ther. 2013 Sep;19(9):649-58. | |
| Mouse dorsal root ganglion neurons | 300 nM | A-803467 selectively blocked Nav1.8 channels, reduced the excitability of DRG neurons in HDC−/− mice, and blocked repetitive action potential firing. | CNS Neurosci Ther. 2013 Sep;19(9):649-58. | |
| Ventricular myocytes | 100 nM | To evaluate the effect of Nav1.8 inhibitor A-803467 on INa,Late, results showed no significant effect of A-803467 on INa,Late | Int J Mol Sci. 2022 May 20;23(10):5735. | |
| Administration | Dosage | Frequency | Description | References | ||
| Dogs | Acute atrial fibrillation model | Injection into ganglionated plexi | 1 μmol/0.5 mL per GP | Single injection followed by 6-hour rapid atrial pacing | To evaluate the effect of A-803467 on an acute atrial fibrillation model. Results showed that A-803467 significantly reduced the incidence of AF, shortened AF duration, and prolonged AF cycle length. | J Am Heart Assoc. 2016 Nov 2;5(11):e004050. |
| Canine | Acute ischemia-induced ventricular arrhythmia model | Left stellate ganglion injection | 10 mM, 15 mM, 20 mM | Single injection | Blocking the Nav1.8 channel could significantly attenuate ischemia-induced VA, primarily by suppressing LSG activity | Sci Rep. 2017 Apr 3;7(1):534 |
| Sprague-Dawley rats | Sciatic nerve transection-repair model | Infusion around the injured site | 10 μM | For 3 days | A-803467 significantly attenuated Nav1.8 upregulation after sciatic nerve transection and promoted axon regeneration. | Anesthesiology. 2023 Dec 1;139(6):782-800 |
| Mice | Wild-type mice | Intraperitoneal injection | 25 mg/kg | Single dose, recorded for 45 minutes | To validate the role of NaV1.8 in the cardiac response to atropine. Results showed that the heart rate response to atropine was significantly lower in wild-type mice after A-803467 treatment. | Front Pharmacol. 2020 Jul 31;11:1163 |
| Rats | Neuropathic pain model (L5/L6 spinal nerve injury) | Intraperitoneal injection | 47 mg/kg | Single dose | Reduce mechanical allodynia | Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5. |
| Wistar rats | Osteoarthritis model | Intra-arterial injection | 500 μg | Single injection | A-803467 significantly reduced the firing rate of joint afferents during noxious rotation of the joint but had no effect during non-noxious rotation. In the pain studies, peripheral injection of A-803467 into OA knees attenuated hindlimb incapacitance and secondary allodynia. | Arthritis Res Ther. 2012 Jan 7;14(1):R5. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.79mL 0.56mL 0.28mL |
13.97mL 2.79mL 1.40mL |
27.95mL 5.59mL 2.79mL |
|
| CAS号 | 944261-79-4 |
| 分子式 | C19H16ClNO4 |
| 分子量 | 357.79 |
| SMILES Code | O=C(C1=CC=C(C2=CC=C(Cl)C=C2)O1)NC3=CC(OC)=CC(OC)=C3 |
| MDL No. | MFCD10574689 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | VHKBTPQDHDSBSP-UHFFFAOYSA-N |
| Pubchem ID | 16038374 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(139.75 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1